Your browser doesn't support javascript.
loading
Corrigendum: Research progress of targeted therapy combined with immunotherapy for hepatocellular carcinoma.
Xie, Shuqi; Wang, Mengchao; Zeng, Chuanxiu; Ou, Yan; Zhao, Lu; Wang, Dong; Chen, Liwei; Kong, Fanming; Yi, Dan.
Afiliación
  • Xie S; Department of Oncology, The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.
  • Wang M; Department of Oncology, The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.
  • Zeng C; Department of Oncology, The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.
  • Ou Y; Department of Oncology, The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.
  • Zhao L; Department of Oncology, The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.
  • Wang D; Department of Oncology, The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.
  • Chen L; Department of Oncology, The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.
  • Kong F; Department of Oncology, The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.
  • Yi D; Department of Oncology, The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Front Oncol ; 13: 1338060, 2023.
Article en En | MEDLINE | ID: mdl-38162493
ABSTRACT
[This corrects the article DOI 10.3389/fonc.2023.1197698.].
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2023 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2023 Tipo del documento: Article País de afiliación: China